Clinical Trial Results: Prolonged Pulsatile Kisspeptin Administration in Hypogonadotropic Hypogonadism [Phase 2]

View source ↗

Summary

Phase 2 trial results evaluating prolonged pulsatile kisspeptin administration for hypogonadotropic hypogonadism.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hypogonadotropic Hypogonadism

Drugs mentioned

• Kisspeptin (Kisspeptin)

Snippet

Sponsor: Stephanie B. Seminara, MD | Conditions: Hypogonadotropic Hypogonadism | Phase 2 | Status: COMPLETED | Results posted: 2026-08-26